Plato BioPharma is a world-class preclinical drug discovery CRO specializing in vivo physiological and pharmacological studies.
Plato BioPharma has raised $3.0M in total funding. The most recent round was Debt Financing. The last funding was announced in October 2021.
Plato BioPharma is headquartered in Westminster, United States.
Plato BioPharma is a world-class preclinical drug discovery CRO specializing in vivo physiological and pharmacological studies.
Plato BioPharma is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Plato BioPharma — Funding & Investors." VCBacked, October 20, 2021, https://www.vcbacked.co/company/plato-biopharma. Accessed September 30, 2026.
VCBacked. (2021). Plato BioPharma — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/plato-biopharma
{{cite web |title=Plato BioPharma — Funding & Investors |url=https://www.vcbacked.co/company/plato-biopharma |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated